ing sugar, protein, triglycerides, and lactate dehydrogenase, while the microbiological analyses consisted of Gram stain, acid fast bacillus smear and culture, and the pleural fluid adenosine deaminase (ADA) level measurements. All patients underwent detailedclinical evaluations with disease history and clinical examinations. Chest computerized tomography (CT) was performed to evaluatethe pleural and parenchymal pathologies and assessthe feasibility of thoracoscopy. All patients underwent VATS for definitive diagnosis and, if necessary, palliative therapy. The patients who could not undergothoracoscopy due to advanced adhesions anddid not tolerate general anesthesia or lung ventilation were not included in the study. All the patients underwent general anesthesia and double lumen intubation at the lateral decubitus position. First, we placed a 10-millimeter port in the sixth intercostal space at the mid-axillary line and the second port in the fourth intercostal space at the anterior axillary line. After the lung was deflated and all pleural surfaces were observed, pleural fluid was fully aspirated and sent for cytology and culture. Biopsies were taken from the pathological lesions on the pleura. Talc pleurodesis was performed in each case diagnosed as malignant pleurisy by thoracoscopic observation. The trucut biopsies were performed incases where a lung mass was detected by chest CT. Also, patients with a peripheral pulmonary nodule underwent wedge resection by endostapler. Hemostasiswas controlled by electrocautery. The procedure was completed by inserting a chest tube in the telescopic incision. Thelung expansion was checked by chest X-ray.The chest drains were removed when the lungexpanded and drainage was less than 50 mL per 24 hours.
Patients' data were retrospectively analyzed in terms of age, gender, symptoms, previously diagnosed cancers, chest CT findings, histopathological diagnosis, cytological diagnosis, morbidity, mortality, and procedure success rates. Patient groups from the three centers were divided into three groups according to the center of the patient. The groups were compared statistically in terms of cytologic diagnosis rates. The Ethics Committee of Adıyaman University Medical School approved the study protocol (5/22/2018, 2018/4-6).
Statistical Analysis
We conducted the study according to the principles of the Declaration of Helsinki. We used the Statistical Package for the Social Sciences 16.0 (SPSS Inc.; Chicago, IL, USA) software for statistical analysis. A chi-squared test was utilized to compare the differences between the groups. A p-value <0.05 was considered to bestatistically significant.
RESULTS
The majority of cases were male patients (161 males and 102 females). The most common complaint was dyspnea 66.5%. One hundred and eighty cases had no malignant disease, where as 83 cases had previously diagnosed cancer. Single PE (66.5%) was the most frequently observed radiological finding. Clinical and radiological characteristics of 263 patients are presented in Table 1 . The histopathological data could be obtainedfrom 249 of 263 patients. The definitive diagnosis was achieved in 242 (97.2%) of 249 patients, while the specific diagnosis was not obtained in only 7 (2.8%) patients. The success rate for definitive diagnosis was detected at 97%. The success rate of palliative therapy was found to be 95%. The histopathological characteristics are presented in Table 2 . Cytopathological data were obtained from 195 patients. The specific cytological diagnosis could be set in only 67 of 195 patients. The cytologic diagnosis rate was significantly lower in Group 1 than in Groups 2 and 3 (p=0.000). The cytological characteristics are presented in Table 3 . The postoperative morbidity rate was detected as 9% (n=24; Table 4). Also, the mortality rate was 2.7% (n=7).
DISCUSSION
Many recent studies have investigated some novel cancer biomarkers including ADA, tumor necrosis factor, interleukin-6, ceroreactiveprotein, carcinoembryonic antigen [4] , vascular endothelial growth factor [5] , reactive oxygenemetabolites [6] , and ceruloplasmine [7] in pleural fluid for discriminating between malign pleurisy (MP) and benign pleurisy (BP), but there is still a lack of diagnostic MP markers with sufficient sensitivity and specificity, which drove us to find and test novel biomarkers [8, 9] . Of these biomarkers, only ADA shows high sensitivity and specificity for tuberculosis (TBC) pleurisy. If a patient has a lymphocytic pleurisy and an ADA level greater than 45 U/mL, it is highly probable that PE is dependent on the TBC pleuritis. In such patients, it is not necessary to confirm the diagnosis of TBC pleuritis by pleural biopsy [10] .
Cytologic studies of the pleural fluid may reveal if pleurisy is malignant or benign. A positive cytology rate is approximately 60% in patients with MP [11] . Factors such as the type of tumor, pleural tumor burden, and expertise of the cytologist determine the success rate of cytologic diagnostic studies [12] . Traditionally, when the pleural fluid cytologic diagnostic studies fail, the next step is the closed pleural biopsy. It is a cheaper and easily accessible method. However, in the literature, diagnostic rates of covered pleural biopsy are approximately 44% [13] . In a recent comparative study, while the success rate of closed pleural biopsies was only 21.7%, success rates of medical thoracoscopic pleural biopsies were found to be 78.3% [14] . Recently, a large number of studies on medical thoracoscopy have been published. However, diagnostic effectiveness of medical thoracoscopy seems to be behind the VATS [15, 16] .
As a more current practice, the pleural biopsy can be performed under the guidance of a chest CT or ultrasound (USG). According to a prospective study performed by Metintas et al. [17] , diagnostic sensitivity of the chest CT guided-needle pleural biopsy in patients with PE is approximately 82%. It was detected that the chest USG-guided needle pleural biopsy had a 66% diagnostic sensitivity in the same study. But the imaging-guided pleural biopsies require experienced interventional radiologists, and it is not possible in all hospitals. In general, approximately 50% of all patients with PE cannot be diagnosed after the initial diagnostic thoracentesis [8] .
Because of the limiting reasons mentioned above, in many centers including ours, a non-diagnostic thoracentesis is followed by thoracoscopy [18] . Our study showed that the most common symptom and chest CT finding were dyspnea and single PE. The clinical and radiological features were similar to the world literature [5, 18, 19] . We also detected that in our large study group, VATS had high diagnostic success with favorable morbidity and mortality rates. In our study, which included patients from three different centers, the rate of cytologic specific diagnosis was similar to the one in the world literature in Groups 2 and 3 [11, 20] . However, the rate of cytologic specific diagnosis in Group 1 was very low, which should be taken under consideration. There is no doubt that the reason for this is the absence of an experienced cytopathologist in this center. Furthermore, it should also be kept in mind that the presence of experienced interventional radiologist outside advanced centers is almost impossible. Therefore, since there are no experienced radiologists and cytologist in our center, it is almost impossible to diagnose pleural pathologies with pleural biopsy by imaging or cytology of pleural fluid. Moreover, single PE is the most frequently observed radiological feature for PE, and therefore, the probability of a diagnostic closed pleural biopsy is very low. On the other hand, we believe that rapid and highly successful diagnostic methods should be used early on in cases of unexplained exudative PE due to the need for definitive diagnosis, initiation of specific or palliative treatment, and prognosis determination.
In conclusion, VATS is not only a rapid and effective diagnostic method, but also a palliative therapeutic method. We think that VATS should be used right after the diagnostic work conducted with initial thoracentesis in undiagnosed exudative PE in the less experienced centers so that a diagnosis can be obtained faster, and diagnostic delay can be avoided in malignant PE. 
